Group of a novel anti-cancer compounds with specific structure
US7129366B2 · kind B2 · utility
3Cited by
1References
12Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Aug 2, 2002 |
| Grant date | Oct 31, 2006 |
| Priority date | — |
| Expiry date | Aug 2, 2022 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D473/34
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Compounds containing a specific saturated or unsaturated branched chain terminal group; a polar leading group; and a long-chain aliphatic, non-cyclic, saturated or unsaturated, substituted or unsubstituted, hydrocarbon group linking them; and having anti-cancer, immunosuppression alleviation, immune boosting and anti-inflammation activity.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.